Another vaccine to prevent coronavirus in the United States has yielded results, with the modern vaccine providing up to 95% protection against the epidemic.
The corona virus, a new vaccine developed by two US-based companies, has been tested on 30,000 people, with a result rate of 94.5%.
According to the British Broadcasting Corporation, it is too early to say how long the vaccine will last. During the trial, volunteers were given two doses of the vaccine. However, the pharmaceutical company says that the results so far have been that the effect of the vaccine has not diminished over time.
A few days ago, the American pharmaceutical company Pfizer also claimed that the coronavirus vaccine developed by it is up to 90% effective. According to the company, the vaccine, developed jointly with the German pharmaceutical company BioNTech, has proved to be 90% effective in preventing coronavirus in the third trial phase.